PYC 9.09% 12.0¢ pyc therapeutics limited

pyc rises 4 days in a row- up 24.2% last week, page-12

  1. 1,431 Posts.
    lightbulb Created with Sketch. 97
    *waves hand as an accountant*

    The R&D tax incentive (introduced 1 July 2011) is a 45% cash offset available on expenses relating to eligible R&D expenditure for eligible companies with turnover below $20M per annum.

    This is actually quite substantial for the cash-flow of eligible businesses as it allows them to make the R&D dollars go almost 50% further.

    Not surprisingly we are working with a number of Bio's (and other businesses) as this is an extremely attractive benefit for eligible firms.

    For PYC, this is likely to lessen the burden of capital requirements for R&D activities. Things like admin expenditures, admin/management wages may not be counted however, so the proportion of eligible R&D expenditure/other expenditure would dictate how beneficial this would be for PYC's cashflow planning
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.010(9.09%)
Mkt cap ! $559.9M
Open High Low Value Volume
11.0¢ 12.0¢ 11.0¢ $198.5K 1.712M

Buyers (Bids)

No. Vol. Price($)
6 635733 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 79848 3
View Market Depth
Last trade - 11.07am 22/08/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.